In today’s challenging home medical equipment (HME) landscape, delivering financial performance requires more than just keeping up. It demands a proactive, strategic approach to revenue cycle management. That’s why Prochant’s CEO Joey Graham and NuCara Home Medical’s CEO Matthew Flatt are teaming up for a results-driven conversation that reveals how top-performing HME providers are transforming operations and achieving real outcomes.

Paula Roth, VP of Pharmacy Operations at Prochant, and Rachel Ewell, Director of Payer Contracts at Amerita, joined NHIA for a timely and tactical webinar focused on managing and preventing denials in the infusion space.

Mastering Reimbursement: Challenges, Solutions, and Metrics That Matter, featuring Joey Graham, CEO of Prochant, and Andrea Stark, Owner of MiraVista.

Joey Graham and Rachel Schools talked about AI and automation in HME intake at MedTrade 2025 and gave a realistic view of what’s possible today and what’s coming—no hype.

Following our recent webinar on "Preventing the Top 5 HME Denials," we received numerous questions from attendees about specific denial scenarios. Andrea Stark from Miravista and Joey Graham from Prochant reconvened to answer them in a dedicated follow-up session. Here are some of the key questions and expert insights shared: 

The top 10 HME denials represent more than 50% of all denials. While the focus is often on the top 5 denial reasons, it's essential to shed light on the other 5 denials that providers encounter in their day-to-day operations.

Health systems have been involved in Home Infusion for decades, and many have achieved great success. However, some have consistently faced annual losses, writing off millions. These health systems struggle to manage the complex revenue cycle associated with home infusion.

Are you overwhelmed by RCM metrics in your infusion pharmacy? Discover the 5 essential KPIs every infusion pharmacy must track for revenue cycle management success.